Philips Secures FDA Approval for AI-Enhanced Spectral CT Scanner
Royal Philips announced on Thursday that it has received FDA 510(k) clearance for its Philips Spectral CT Verida system, a medical imaging innovation that combines persistent spectral imaging with AI-driven reconstruction. This system is touted as the first spectral CT detector utilizing AI.
Enhanced Imaging Capabilities
The Verida system integrates persistent spectral imaging with AI reconstruction to enhance image quality, efficiency, and diagnostic capabilities. This technology is targeted at the fields of radiology, cardiology, and oncology.
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning
✓ Euronext data
✓ AI-powered analysis
Indicative data. No investment advice. Unsubscribe at any time.
Related
🏢
Other stocks — Santé
🗞️
MedInCell Stock Drops 2% to €28.14 Despite Raised Target of €52 by Oddo
🗞️
Sartorius Stedim Biotech Shares Slide to €159.10, Remain Under Technical Pressure
🗞️
Nanobiotix Shares Drop to €44.46 After a 1,181% Annual Surge and a Record High of €45.86
🗞️
DBV Technologies Shares at €3.44: Up 77% Over the Year, Heading to the June 3rd General Meeting
